It has begun trading as of Feb. 13 under the ticker symbol “AMDA,” according to news release.
The company is also granting a 30-day opportunity to its underwriters to purchase up to 525,000 additional shares of common stock at the IPO price minus an underwriting discount, according to the release.
The offering will likely close Feb. 19.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
